Significantly oversubscribed new share issue in Carbiotix

Oct 01, 2019, 09:15

On September 26, 2019, the subscription period in Carbiotix AB (“Carbiotix”) new share issue of approx. SEK 12,4 million (including bridge loan and compensation to bridge lenders) prior to listing on Spotlight Stock Market (“Spotlight”) was completed. The interest was significant, and the new share issue was subscribed to a total of approx. SEK 69,8 million, corresponding to a subscription rate of approx. 562 percent. Through the new share issue, a total of 2.790.000 shares will be issued and Carbiotix will be provided approx. SEK 12 million (which excludes the SEK 0.4 million that refers to the compensation mentioned above) before issue costs. Through the new share issue, Carbiotix will receive approx. 950 new shareholders. Settlement notes are scheduled to be sent to all allotted shareholders today. Sedermera Fondkommission is the financial advisor in connection with the new share issue.

CEO Kristofer Cook comments: 

“We are very grateful for the interest in our new share issue and I would like to thank all interested parties who have chosen to invest in Carbiotix and warmly welcome the new shareholders to the company. With the capital that we are now provided, we look forward to continuing our future expansion.”

Subscription and allotment

The new share issue was subscribed to approx. SEK 69,8 million including pre-subscription commitments, corresponding to a subscription rate of approx. 562 percent. 2.790.000 new shares will be issued and Carbiotix is thus now provided approx. SEK 12 million (which excludes the SEK 0.4 million that refers to the compensation) before issue costs, which are estimated to amount to approx. SEK 1,19 million (9,93% of the issue volume). Allotment of shares have been decided upon by the Board of Directors in accordance with the principles stated in the terms and conditions in the memorandum. Settlement notes are expected to be sent out today, October 1, 2019. Subscribers who are not allocated shares will not receive settlement notes.

Number of shares and share capital

When Carbiotix new share issue has been registered at the Companies Registration Office (Bolagsverket), the total number of shares will amount to 8.583.000 shares and the share capital will amount to SEK 858.300.

Listing on Spotlight Stock Market

The first day of trading in Carbiotix shares on Spotlight is expected to be October 18, 2019. Carbiotix shares will be traded under the label "CRBX" and with ISIN code SE0013016128.

Financial adviser and issuing agent

Sedermera Fondkommission is the financial advisor and issuing agent to Carbiotix in connection with the new share issue.

This information is information that Carbiotix AB is obliged to make public according to the EU Market Abuse Regulation (MAR). The information was made publicly available by the Company’s contact person set out below on October 1, 2019.

For further information:
Carbiotix AB
Kristofer Cook, CEO
Tel: 0708-796580
E-mail: kristofer.cook@carbiotix.com

Carbiotix AB (CRBX) (www.carbiotix.com) is a biotechnology company developing Microbiome Modulator Therapeutics (MMT) that amplify the production of key metabolites for the treatment of different metabolic and chronic diseases. The company’s therapeutics are based on a propriety AXOS soluble fiber, isolated bacterial strains, and innovative formulations, supported by cost effective gut health testing services used to regularly diagnose and monitor gut health, and dose therapeutics. 

Go Back